These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3569760)

  • 81. The effect of tobramycin on the renal handling of vancomycin.
    Munar MY; Elzinga L; Brummett R; Golper TA; Bennett WM
    J Clin Pharmacol; 1991 Jul; 31(7):618-23. PubMed ID: 1894757
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid.
    Pichette V; du Souich P
    J Am Soc Nephrol; 1996 Feb; 7(2):345-9. PubMed ID: 8785407
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multiple linear regression modeling of furosemide renal clearance and urinary excretion rate.
    Ponto LL; Schoenwald RD
    J Pharm Sci; 1991 Nov; 80(11):1084-91. PubMed ID: 1815062
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of furosemide on free water excretion in edematous patients with hyponatremia.
    Schrier RW; Lehman D; Zacherle B; Earley LE
    Kidney Int; 1973 Jan; 3(1):30-4. PubMed ID: 4693690
    [No Abstract]   [Full Text] [Related]  

  • 85. Hepatic and renal function in Nigerians with endomyocardial fibrosis.
    Ojo GO
    J Trop Med Hyg; 1970 Oct; 73(10):255-7. PubMed ID: 5478041
    [No Abstract]   [Full Text] [Related]  

  • 86. Overflow theory of ascites formation.
    Lieberman FL
    Gastroenterology; 1989 Jan; 96(1):274. PubMed ID: 2909434
    [No Abstract]   [Full Text] [Related]  

  • 87. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).
    Mandorfer M; Aigner E; Cejna M; Ferlitsch A; Datz C; Gräter T; Graziadei I; Gschwantler M; Hametner-Schreil S; Hofer H; Jachs M; Loizides A; Maieron A; Peck-Radosavljevic M; Rainer F; Scheiner B; Semmler G; Reider L; Reiter S; Schoder M; Schöfl R; Schwabl P; Stadlbauer V; Stauber R; Tatscher E; Trauner M; Ziachehabi A; Zoller H; Fickert P; Reiberger T
    Wien Klin Wochenschr; 2023 Sep; 135(Suppl 3):493-523. PubMed ID: 37358642
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).
    Reiberger T; Püspök A; Schoder M; Baumann-Durchschein F; Bucsics T; Datz C; Dolak W; Ferlitsch A; Finkenstedt A; Graziadei I; Hametner S; Karnel F; Krones E; Maieron A; Mandorfer M; Peck-Radosavljevic M; Rainer F; Schwabl P; Stadlbauer V; Stauber R; Tilg H; Trauner M; Zoller H; Schöfl R; Fickert P
    Wien Klin Wochenschr; 2017 Nov; 129(Suppl 3):135-158. PubMed ID: 29063233
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Continuous furosemide infusion in the management of ascites.
    Rogers NA; Gupta S; Cuthbert JA
    J Investig Med; 2012 Apr; 60(4):671-5. PubMed ID: 22373660
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diagnosis and therapy of ascites in liver cirrhosis.
    Biecker E
    World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites.
    Daskalopoulos G; Laffi G; Morgan T; Pinzani M; Harley H; Reynolds T; Zipser RD
    Gastroenterology; 1987 Jun; 92(6):1859-63. PubMed ID: 3569760
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of captopril on renal function in patients with cirrhosis and ascites.
    Daskalopoulos G; Pinzani M; Murray N; Hirschberg R; Zipser RD
    J Hepatol; 1987 Jun; 4(3):330-6. PubMed ID: 3298415
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Subacute endotoxemia in dogs with experimental cirrhosis and ascites: effects on kidney function.
    Levy M; Wexler MJ
    Can J Physiol Pharmacol; 1984 Jun; 62(6):673-7. PubMed ID: 6378343
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.